194 related articles for article (PubMed ID: 19302195)
1. Lack of CB1 receptor activity impairs serotonergic negative feedback.
Aso E; Renoir T; Mengod G; Ledent C; Hamon M; Maldonado R; Lanfumey L; Valverde O
J Neurochem; 2009 May; 109(3):935-44. PubMed ID: 19302195
[TBL] [Abstract][Full Text] [Related]
2. Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.
Sotty F; Folgering JH; Brennum LT; Hogg S; Mørk A; Hertel P; Cremers TI
Neuropharmacology; 2009 Jul; 57(1):18-24. PubMed ID: 19376075
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.
David DJ; Froger N; Guiard B; Przybylski C; Jego G; Boni C; Hunt SP; De Felipe C; Hamon M; Jacquot C; Gardier AM; Lanfumey L
Eur J Pharmacol; 2004 May; 492(1):41-8. PubMed ID: 15145704
[TBL] [Abstract][Full Text] [Related]
4. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.
Evrard A; Malagié I; Laporte AM; Boni C; Hanoun N; Trillat AC; Seif I; De Maeyer E; Gardier A; Hamon M; Adrien J
Eur J Neurosci; 2002 Mar; 15(5):841-51. PubMed ID: 11906526
[TBL] [Abstract][Full Text] [Related]
5. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
6. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
9. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
Tao R; Ma Z; Auerbach SB
J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
[TBL] [Abstract][Full Text] [Related]
11. Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity.
Calcagno E; Canetta A; Guzzetti S; Cervo L; Invernizzi RW
J Neurochem; 2007 Nov; 103(3):1111-20. PubMed ID: 17666043
[TBL] [Abstract][Full Text] [Related]
12. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
Ferrés-Coy A; Santana N; Castañé A; Cortés R; Carmona MC; Toth M; Montefeltro A; Artigas F; Bortolozzi A
Psychopharmacology (Berl); 2013 Jan; 225(1):61-74. PubMed ID: 22820867
[TBL] [Abstract][Full Text] [Related]
13. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.
Mato S; Aso E; Castro E; Martín M; Valverde O; Maldonado R; Pazos A
J Neurochem; 2007 Dec; 103(5):2111-20. PubMed ID: 17944876
[TBL] [Abstract][Full Text] [Related]
14. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
Knobelman DA; Hen R; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
[TBL] [Abstract][Full Text] [Related]
15. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.
Guiard BP; David DJ; Deltheil T; Chenu F; Le Maître E; Renoir T; Leroux-Nicollet I; Sokoloff P; Lanfumey L; Hamon M; Andrews AM; Hen R; Gardier AM
Int J Neuropsychopharmacol; 2008 Feb; 11(1):79-92. PubMed ID: 17559709
[TBL] [Abstract][Full Text] [Related]
17. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T
Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis.
He M; Sibille E; Benjamin D; Toth M; Shippenberg T
Brain Res; 2001 May; 902(1):11-7. PubMed ID: 11376590
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
20. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse.
Conductier G; Dusticier N; Lucas G; Côté F; Debonnel G; Daszuta A; Dumuis A; Nieoullon A; Hen R; Bockaert J; Compan V
Eur J Neurosci; 2006 Aug; 24(4):1053-62. PubMed ID: 16930432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
